A systematic review on the application of pharmaco­epidemiology in assessing prescription drug-related adverse events in pediatrics

References

• Department of Health and Human Services. Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients. Washington (DC): US Government Printing Office; August, 1997
   Google Scholar
• Griffin MR, Stein CM, Ray WA. Postmarketing surveillance for drug safety: surely we can do better. Clin Pharmacol Ther 2004;75:491–4
   Google Scholar
• Roden DM. An underrecognized challenge in evaluating post-marketing drug safety. Circulation 2005;11:246–8
   Google Scholar
• Ray WA. Population-based studies of adverse drug effects. New Engl J Med 2003;349:1592–4
   PubMed Web of Science ®Google Scholar
• Chan KA, Hernandez-Diaz S. Pharmacoepidemiology and rheumatic disorders. Rheum Dis Clin North Am 2004;30: 835–50, vii
   Google Scholar
• Strom BL. What is pharmacoepidemiology? In: Strom BL, editor. Pharmacoepidemiology, 3rd ed. Chichester, England: John Wiley; 2000. p. 1–15
   Google Scholar
• Hartzema AG, Porta M, Tilson HH. Pharmacoepidemiology: an introduction, 3rd ed. Cincinnati (OH): Harvey Whitney Books Company; 1998
   Google Scholar
• Department of Health & Human Service. HHS launches new pediatric drug safety initiative. April 2002. http://www.hhs.gov/news/press/2002pres/20020419b.html [last accessed: January 2007]
   Google Scholar
• Hambidge SJ, Glanz JM, France EK, et al. Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old. J Am Med Assoc 2006;296:1990–7
   PubMed Web of Science ®Google Scholar
• Vestergaard M, Hviid A, Madsen KM, et al. MMR vaccination and febrile seizures: evaluation of susceptible subgroups and long-term prognosis. J Am Med Assoc 2004;292:351–7
   PubMed Web of Science ®Google Scholar
• Celedon JC, Litonjua AA, Ryan L, et al. Lack of association between antibiotic use in the first year of life and asthma, allergic rhinitis, or eczema at age 5 years. Am J Respir Crit Care Med 2002;166:72–5
   PubMed Web of Science ®Google Scholar
• Chalumeau M, Tonnelier S, D’Athis P, et al. Fluoroquinolone safety in pediatric patients: a prospective, multicenter, comparative cohort study in France. Pediatrics 2003;111: e714–e719
   Google Scholar
• Johnson CC, Ownby DR, Alford SH, et al. Antibiotic exposure in early infancy and risk for childhood atopy. J Allergy Clin Immunol 2005;115:1218–24
   PubMed Web of Science ®Google Scholar
• Drossou-Agakidou V, Roilides E, Papakyriakidou-Koliouska P, et al. Use of ciprofloxacin in neonatal sepsis: lack of adverse effects up to one year. Pediatr Infect Dis J 2004;23:346–9
   Google Scholar
• McKeever TM, Lewis SA, Smith C, et al. Early exposure to infections and antibiotics and the incidence of allergic disease: a birth cohort study with the West Midlands General Practice Research Database. J Allergy Clin Immunol 2002;109:43–50
   PubMed Web of Science ®Google Scholar
• Cooper WO, Griffin MR, Arbogast P, et al. Very early exposure to erythromycin and infantile hypertrophic pyloric stenosis. Arch Pediatr Adolesc Med 2002;156:647–50
   PubMed Web of Science ®Google Scholar
• Cullinan P, Harris J, Mills P, et al. Early prescriptions of antibiotics and the risk of allergic disease in adults: a cohort study. Thorax 2004;59:11–5
   PubMed Web of Science ®Google Scholar
• Clark RH, Bloom BT, Spitzer AR, et al. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics 2006;117:67–74
   PubMed Web of Science ®Google Scholar
• Bremner SA, Carey IM, DeWilde S. Early-life exposure to antibacterials and the subsequent development of hayfever in childhood in the UK: case-control studies using the General Practice Research Database and the Doctors’ Independent Network. Clin Exp Allergy 2003;33:1518–25
   Google Scholar
• Spiro DM, Arnold DH, Barbone F. Association between antibiotic use and primary idiopathic intussusception. Arch Pediatr Adolesc Med 2003;157:54–9
   Google Scholar
• Van Houten MA, Uiterwaal CS, Heesen GJ, et al. Does the empiric use of vancomycin in pediatrics increase the risk for Gram-negative bacteremia? Pediatr Infect Dis J 2001;20:171–7
   PubMed Web of Science ®Google Scholar
• Barkley RA, Fischer M, Smallish L, et al. Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use/abuse? A 13-year prospective study. Pediatrics 2003;111:97–109
   PubMed Web of Science ®Google Scholar
• Katusic SK, Barbaresi WJ, Colligan RC, et al. Psychostimulant treatment and risk for substance abuse among young adults with a history of attention-deficit/hyperactivity disorder: a population-based, birth cohort study. J Child Adolesc Psychopharmacol 2005;15:764–76
   PubMed Web of Science ®Google Scholar
• Valuck RJ, Libby AM, Sills MR, et al. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study. CNS Drugs 2004;18:1119–32
   PubMed Web of Science ®Google Scholar
• French NP, Hagan R, Evans SF, et al. Repeated antenatal corticosteroids: effects on cerebral palsy and childhood behavior. Am J Obstet Gynecol 2004;190:588–95
   PubMed Web of Science ®Google Scholar
• van Staa TP, Cooper C, Leufkens HG, et al. Children and the risk of fractures caused by oral corticosteroids. J Bone Miner Res 2003;18:913–8
   PubMed Web of Science ®Google Scholar
• van Staa TP, Bishop N, Leufkens HG, et al. Are inhaled corticosteroids associated with an increased risk of fracture in children? Osteoporosis Int 2004;15:785–91
   PubMed Web of Science ®Google Scholar
• Schlienger RG, Jick SS, Meier CR. Inhaled corticosteroids and the risk of fractures in children and adolescents. Pediatrics 2004;114:469–73
   Google Scholar
• Scholes D, LaCroix AZ, Ichikawa LE, et al. Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception. Arch Pediatr Adolesc Med 2005;159:139–44
   PubMed Web of Science ®Google Scholar
• Cromer BA, Stager M, Bonny A, et al. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. J Adolesc Health 2004;35:434–41
   PubMed Web of Science ®Google Scholar
• Bonny AE, Ziegler J, Harvey R, et al. Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method. Arch Pediatr Adolesc Med 2006;160:40–5
   PubMed Web of Science ®Google Scholar
• Venn A, Bruinsma F, Werther G, et al. Oestrogen treatment to reduce the adult height of tall girls: long-term effects on fertility. Lancet 2004;64:1513–8
   Google Scholar
• Buchacz K, Cervia JS, Lindsey JC, et al. Impact of protease inhibitor-containing combination antiretroviral therapies on height and weight growth in HIV-infected children. Pediatrics 2001;108:E72
   PubMed Web of Science ®Google Scholar
• Sturkenboom M, Nicolosi A, Cantarutti L, et al. Incidence of mucocutaneous reactions in children treated with niflumic acid, other nonsteroidal antiinflammatory drugs, or nonopioid analgesics. Pediatrics 2005;116:e26–e33
   PubMed Web of Science ®Google Scholar
• Menniti-Ippolito F, Sagliocca L, Da Cas R, et al. Niflumic acid and cutaneous reactions in children. Arch Dis Child 2001;84:430–1
   PubMed Web of Science ®Google Scholar
• Chia CY, Lane W, Chibnall J, et al. Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: a cohort study. Arch Dermatol 2005;141:557–60
   PubMed Web of Science ®Google Scholar
• Canani RB, Cirillo P, Roggero P, et al. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics 2006;117:e817–e820
   PubMed Web of Science ®Google Scholar
• Wong IC, Murray ML. The potential of UK clinical databases in enhancing paediatric medication research. Br J Clin Pharmacol 2005;59:750–5
   PubMed Web of Science ®Google Scholar
• Martin A, Van Hoof T, Stubbe D, et al. Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid Managed Care. Psychiatric Services 2003;54:72–7
   PubMed Web of Science ®Google Scholar
• Safer DJ, Zito JM, DosReis S. Concomitant psychotropic medication for youths. Am J Psychiatry 2003;160:438–49
   PubMed Web of Science ®Google Scholar
• Juurlink DN, Mamdani MM, Kopp A, et al. A population-based assessment of the potential interaction between serotonin-specific reuptake inhibitors and digoxin. Br J Clin Pharmacol 2005;59:102–7
   PubMed Web of Science ®Google Scholar
• Juurlink DN, Mamdani M, Kopp A, et al. Drug–drug interactions among elderly patients hospitalized for drug toxicity. J Am Med Assoc 2003;289:1652–8
   PubMed Web of Science ®Google Scholar
• Schirm E, Tobi H, de Jong-van den Berg LT. Unlicensed and off label drug use by children in the community: cross-sectional study. Br Med J 2002;324:1312–3
   Google Scholar